19 followers
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials. - PubMed - NCBI https://t.co/mczi94WMa1
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials. - PubMed - NCBI https://t.co/mczi94WMa1
RT @psychopharmacol: meta-analysis: In MDD patients not responding to their 1st trial with antidepressants, aripiprazol was associated with…
meta-analysis: In MDD patients not responding to their 1st trial with antidepressants, aripiprazol was associated with a higher remission rate (RR=1.64; 1.42 to 1.89) than other treatments https://t.co/F76Xh6NWgk